Harmful Effects of Actos Drug. Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective drugs, has filed a lawsuit alleging that Actos caused bladder cancer in a North Carolina man.
The suit was filed on September 17th in the U.S. District Court for the Western District of Louisiana (Case No. 6:12-cv-2490). There, it is one of many similar cases pending in the multidistrict litigation known as In Re: Actos (Pioglitazone) Products Liability Litigation (MDL No. 6:11-md-2299). Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals USA, Inc. f/k/a Takeda Pharmaceuticals North America. Inc., Takeda Pharmaceutical Company Limited and Eli Lilly and Company.
According to the Complaint, the Plaintiff took ‘Actos’ from 2004 to 2012. He developed bladder cancer in 2009, and alleges that the cancer is a direct result of taking the drug. The suit alleges that the Defendants sold the drug despite knowing about the risk of bladder cancer. Among other things, the lawsuit is seeking compensation for severe mental and physical pain and suffering, permanent injuries, emotional distress, economic loss due to medical expenses and living related expenses due to a new lifestyle.
Last summer, the U.S. Food and Drug Administration (FDA) updated the label on Actos warning that use of the drug for more than one year could significantly raise the risk of bladder cancer. At around the same time, use of Actos was suspended in France and Germany because of its link to bladder cancer.
Research continues to support the association between Actos and bladder cancer
Research continues to support the association between Actos and bladder cancer. Last month, the Journal of the National Cancer Institute published a study showing that the long-term use of ‘Actos’ and other thiazolidinediones (TZDs) could raise the risk of bladder cancer. The month prior, the Canadian Medical Association Journal published a study evaluating data from approximately 2.6 million people, and found that patients using Actos were 22 percent more likely to develop bladder cancer.
According to a recent article in Consumer Reports, Actos should be considered a last resort treatment for patients who have type 2 diabetes. The report pointed out that, even though the drug has gone generic, there are several other options with fewer risks, such as metformin, glipizide and glimepiride.
Parker Waichman LLP continues to offer free legal consultations to victims of Actos injuries, including bladder cancer, heart problems, and eye injuries. If you or a loved one were diagnosed with bladder cancer after taking Actos, please contact their office by visiting https://yourlawyercom.wpengine.com. Free case evaluations are also available by calling 1-800-YOURLAWYER (1-800-968-7529).
Need Legal Help Regarding Actos?
The personal injury attorneys at Parker Waichman LLP offer free, no-obligation case evaluations. For more information, fill out our online contact form or call 1-800-YOURLAWYER (1-800-968-7529).
Contact:
Parker Waichman LLP
Gary Falkowitz, Managing Attorney
(800) YOURLAWYER
(800) 968-7529
https://yourlawyercom.wpengine.com
Contact
- Gary Falkowitz, Managing Attorney
Parker Waichman LLP
1-800-968-7529
Email
Follow us on: 
New York | Brooklyn | Queens | Long Island | New Jersey | Florida
Call us at: 1-800-YOURLAWYER (800-968-7529) | Schedule your free consultation
Our Actos exposure lawyers are here to help you when you need it the most.
